Abstract:BACKGROUND:Non-cystic fibrosis bronchiectasis is characterized by the irreversible dilatation of the medium-sized bronchi as a result of airway injury from recurrent or chronic inflammation and lower respiratory tract infections. Bronchiectasis airways are commonly colonized with bacterial species. Infections of the airways play important role in bronchiectasis exacerbations. The non-specific prevention of recurrent airway infections by immunostimulating agents has gained growing interest. OM-85, consisting of extracts of eight kinds of bacteria important in respiratory infections, could support the respiratory tract resistance to the pathogens. OM-85 has been shown to be a benefit by decreasing the risk of acute exacerbation of chronic obstructive pulmonary disease (COPD) in several perspective clinical trials. Exacerbation of bronchiectasis substantially contributes to a more rapid decline in lung function, reduced quality of life, and healthcare costs. In this context, we plan to conduct a clinical trial to investigate the PReventive effect of OM-85 on Bronchiectasis Exacerbation in Chinese patients (iPROBE).METHODS/DESIGN:This study is designed as a prospective, randomized, double blind, placebo-controlled multicenter trial. A total of 244 patients with bronchiectasis, who have had at least one exacerbation of bronchiectasis in the previous year, will be included. The subjects will randomly receive two courses of 7 mg of OM-85 or a matching placebo. The treatment dose of OM-85 will be one daily capsule taken orally for 10 days each month for 3 consecutive months at the beginning of the study, followed by 3 months of no drug. This schedule will repeat until the patient has been seen for one year.DISCUSSION:We will investigate whether long-term treatment with an oral immunostimulant (OM-85) could decrease exacerbations of bronchiectasis over a one-year period. We will also assess other relevant outcomes, including the rate of event-based exacerbation, lung function parameters, and total scores judged by the St George's respiratory questionnaire, Leicester cough questionnaire, and inflammatory index. We hope that this study will provide new information on the preventive effects of OM-85 on bronchiectasis exacerbations and will address a knowledge gap for this understudied disease.TRIAL REGISTRATION:This study is registered at http://www.clinicaltrials.gov (identifier NCT01968421) on 19 October 2013.

Clinical study of Biostim to improvation of recurrent lower respiratory tract infection in obstructive lung diseases

Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial

Therapeutic effect of ipratropium bromide combined with long-term domiciliary oxygen therapy for patients with chronic obstructive pulmonary disease

Clinical Study of Inhaled Ambroxol in the Adjunctive Treatment of Lower Respiratory Tract Infection Induced by Pseudomonas Aeruginosa

Effect of OM-85 BV on Reducing Bronchiectasis Exacerbation in Chinese Patients: the Iprobe Study.

To Investigate the Prevention of OM-85 on Bronchiectasis Exacerbations (iprobe) in Chinese Patients: Study Protocol for a Randomized Controlled Trial

Analysis on Clinical Materials from 76 Cases of COPD Treated with Qi-Replenishing, Blood-Activating and Phlegm-Removing Therapy

Effect of inhalation drug therapy on inflammatory factors and quality of life on stable chronic obstructive pulmonary disease

Double-Blind Randomized Placebo Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary Disease

Efficacy and safety of tiotropium bromide inhalation in symptomatic patients with chronic obstructive pulmonary disease: A multicenter, prospective, and observational study

Long-term Management Program Can Improve Control Status of Stable COPD

Effects of probiotic treatment on patients and animals with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized control trials

Clinical Research on 178 Cases of Chronic Obstructive Pulmonary Disease in T He Stable Stage Treated with Jianpi Yifei II

Effects of Qi-supplementing, Blood-activating And Phlegm-resolving on Lung Function And Blood Coagulationin Among Patients of Chronic Obstructive Pulmonary Disease in Acute Stage

Interventional effects of different management programs on the outcomes of stable chronic obstructive pulmonary disease patients]

Clinical efficacy of TCM formula of replenishing qi and resolving phlegm and dispelling stasis on patients with stable chronic obstructive pulmonary disease

Effects of co-application of tiotropium bromide and traditional Chinese medicine on patients with stable chronic obstructive pulmonary disease: a muilticenter, randomized, controlled trial study

Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease

Study on the therapeutic effects and prognosis evaluation of non-invasive ventilation in patients with chronic obstructive pulmonary disease with lung cancer

Effect of the combination of respiratory care with bronchodilators on pulmonary function, psychological well being, and health behaviors in COPD patients

Effect of high-flow nasal oxygen therapy combined with ipratropium bromide on Th1/Th2 balance and inflammation in patients with chronic obstructive pulmonary disease and respiratory failure